Erschienen in:
10.05.2020 | COVID-19 | Correspondence
Zur Zeit gratis
Glucocorticoid versus immunoglobulin in the treatment of COVID-19-associated fulminant myocarditis
verfasst von:
Chia Siang Kow, Syed Shahzad Hasan
Erschienen in:
Infection
|
Ausgabe 5/2020
Einloggen, um Zugang zu erhalten
Excerpt
We read with interest the case report on fulminant myocarditis associated with novel Coronavirus disease 2019 (COVID-19) by Zeng et al. [
1]. The comprehensive discussion on this interesting case is very much appreciated with a description of the treatment plan which included corticosteroid therapy (methylprednisolone) and intravenous immunoglobulin (IVIG). While we acknowledge that corticosteroid and IVIG may be indicated for acute respiratory distress syndrome that was also present in the subject, we would like to discuss their use in the context of fulminant myocarditis. …